The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

Purpose. The goal of these studies was to provide proof of concept for a novel targeted therapy for Glioblastoma Multiforme (GBM). Methods. These studies involve the evaluation of reconstituted high density lipoprotein (rHDL) nanoparticles (NPs) as delivery agents for the drug, mammalian Target of R...

Full description

Bibliographic Details
Main Authors: Ethan Berney, Nirupama Sabnis, Marlyn Panchoo, Sangram Raut, Rob Dickerman, Andras G. Lacko
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Oncology
Online Access:http://dx.doi.org/10.1155/2019/1805841